To test whether JNK deficiency promotes tumorigenesis by disrupting the balance of proliferation and cell death, we stained tumor tissue sections with antibodies to detect the proliferation marker PCNA and the apoptotic marker cleaved caspase 3. Here, CASP3 is linked to neoplasm.